News

Best Buy to Offer Prescription-Based Continuous Glucose Monitoring System

1 Mins read

Electronics retailer Best Buy Co. Inc. announced on Monday that it will soon begin offering a continuous glucose monitoring system (CGM), marking its first venture into the prescription-based medical device market. The new Dexcom G7 CGM will be available to eligible customers through BestBuy.com, and they will be directed to complete the purchase process on the newly established platform Wellness.BestBuyHealth.com.

According to data from the Centers for Disease Control and Prevention, over 10% of the U.S. population has diabetes. Best Buy acknowledges the growing demand for CGMs over the past few years and highlights the benefits of using devices like Dexcom G7, including real-time glucose monitoring without the need for fingersticks. This advancement empowers individuals to make more informed decisions about managing their diabetes.

At the initial launch, Best Buy will not be able to accept insurance payments. However, customers who have funds in their HSA/FSA/HRA accounts may be eligible for reimbursement for their CGM purchase.

Year-to-date, Best Buy stock has declined by 14%, whereas the S&P 500 has seen a 12% gain.

Related posts
News

LSEG Rides Market Volatility To Solid H1 Growth, Fueled By Tradeweb, FX - FinanceFeeds

1 Mins read
The London Stock Exchange Group (LSEG) posted a stronger-than-expected first half, brushing off market volatility with double-digit growth in its core trading…
News

Coinbase Unveils 'Everything Exchange' Bringing Tokenized Stocks to US Users

1 Mins read
Coinbase said it will begin offering tokenized stocks, derivatives, prediction markets and early-stage token sales to U Coinbase said it will begin…
News

High Risk 100 USD SAR Expert Advisor Settings

1 Mins read
DISCLAIMER: Forex trading has a risk of losing all your money. Martingale and hedging systems that we have used now are kind…

Leave a Reply

Your email address will not be published. Required fields are marked *